Acupuncture Therapy for COVID-Related Olfactory Loss


About this study

The objectives of this study are to describe the incidence of COVID-related olfactory loss, to compare the effectiveness of acupuncture, steroid rinses, and olfactory training versus steroid rinses and olfactory training in the treatment of COVID-related olfactory loss, and to recommend a treatment paradigm for patients with COVID-related olfactory loss.


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • 18 years or older.
  • Patients with post-viral olfactory dysfunction > 4 weeks.
  • History of positive COVID-19 PCR.

Exclusion Criteria:

  • Less than 18 years of age.
  • Active sinus infection.
  • New diagnosis of untreated CRS.
  • Prior diagnosis of dementia or Parkinson’s disease.
  • Prior head trauma or neurosurgical procedure resulting in olfactory loss.
  • Patients who do not speak or read English.
  • Patients unable to understand and sign the study consent.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Janalee Stokken, M.D.

Closed for enrollment

Contact information:

Amy Tuchscherer C.C.R.C.

(507) 538-6582

More information


Publications are currently not available

Mayo Clinic Footer